Advances in fish cytokine biology give clues to the evolution of a compex network

Current Pharmaceutical Design

Volumn 12, Issue 24, 2006, Pages 3051-3069

  Bird, S ^a   Zou, J ^a   Secombes, C J ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Cell mediated immunity; Cytokine evolution; Humoral immunity; T helper 1 (Th1); T helper 2 (Th2); Teleost; Xenopus

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9; LYMPHOTOXIN; TRANSFORMING GROWTH FACTOR BETA;

ADAPTATION; BIOLOGY; BIRD; FISH; HUMAN; IMMUNE SYSTEM; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; MAMMAL; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; SPECIES DIFFERENTIATION; TH1 CELL; TH2 CELL; VERTEBRATE;

ANIMALS; ANTIBODY FORMATION; CYTOKINES; EVOLUTION, MOLECULAR; FISHES; HUMANS; IMMUNITY, CELLULAR; MAMMALS;

EID: 33747152222     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161206777947434     Document Type: Review

References (315)

1. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136: 2348-57.
2. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145-73.
3. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17: 138-46.
4. Seder RA, Paul WE. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol 1994; 12: 635-73.
5. Hosken NA, Shibuya K, Heath AW, Murphy KM, O'Garra A. The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. J Exp Med 1995; 182: 1579-84.
6. Glimcher LH, Murphy KM. Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes Dev 2000; 14: 1693-711.
7. Murphy KM, Ouyang W, Farrar JD, Yang J, Ranganath S, Asnagli H, Afkarian M, Murphy TL. Signaling and transcription in T helper development. Annu Rev Immunol 2000; 18: 451-94.
8. O'Garra A. T-cell differentiation: Commitment factors for T helper cells. Curr Biol 2000; 10: R492-R494.
9. Szabo SJ, Sullivan BM, Peng SL, Glimcher LH. Molecular mechanisms regulating Th1 immune responses. Annu Rev Immunol 2003; 21: 713-58.
10. Wenner CA, Guler ML, Macatonia SE, O'Garra A, Murphy KM. Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development. J Immunol 1996; 156: 1442-7.
11. Rogge L, D'Ambrosio D, Biffi M, Penna G, Minetti LJ, Presky DH, et al. The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J Immunol 1998; 161: 6567-74.
12. Berenson LS, Ota N, Murphy KM. Issues in T-helper 1 development - resolved and unresolved. Immunol Rev 2004; 202: 157-74.
13. Miller JF, Morahan G. Peripheral T cell tolerance. Annu Rev Immunol 1992; 10: 51-69.
14. Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001; 2: 816-22.
15. Maloy KJ, Salaun L, Cahill R, Dougan G, Saunders NJ, Powrie F. CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 2003; 197: 111-9.
16. Cher DJ, Mosmann TR. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. J Immunol 1987; 138: 3688-94.
17. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383: 787-93.
18. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 1998; 8: 275-83.
19. Romagnani S. The Th1/Th2 paradigm. Immunol Today 1997; 18: 263-6.
20. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989; 170: 827-45.
21. Wolf SF, Temple PA, Kobayashi M, Young D, Dicig M, Lowe L, et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 1991; 146: 3074-81.
22. Gubler U, Chua AO, Schoenhaut DS, Dwyer CM, McComas W, Motyka R, et al. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci USA 1991; 88: 4143-7.
23. Kato T, Hakamada R, Yamane H, Nariuchi H. Induction of IL-12 p40 messenger RNA expression and IL-12 production of macrophages via CD40-CD40 ligand interaction. J Immunol 1996; 156: 3932-8.
24. Koch F, Stanzl U, Jennewein P, Janke K, Heufler C, Kampgen E, et al. High level IL-12 production by routine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med 1996; 184: 741-6.
25. Ma X, Chow JM, Gri G, Carra G, Gerosa F, Wolf SF, et al. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J Exp Med 1996; 183: 147-57.
26. Schulz O, Edwards AD, Schito M, Aliberti J, Manickasingham S, Sher A, et al. CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 2000; 13: 453-62.
27. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003; 3: 133-46.
28. Degen WGJ, van Daal N, van Zuilekom HI, Burnside J, Schijns VEJC. Identification and molecular cloning of functional chicken IL-12. J Immunol 2004; 172: 4371-80.
29. Yoshiura Y, Kiryu I, Fujiwara A, Suetake H, Suzuki Y, Nakanishi T, et al. Identification and characterization of Fugu orthologues of mammalian interleukin-12 subunits. Immunogenetics 2003; 55: 296-306.
30. Yoon C, Johnston SC, Tang J, Stahl M, Tobin JF, Somers WS. Charged residues dominate a unique interlocking topography in the heterodimeric cytokine interleukin-12. EMBO J 2000; 19: 3530-41.
31. Watford WT, Moriguchi M, Morinobu A, O'Shea JJ. The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev 2003; 14: 361-8.
32. Babik JM, Adams E, Tone Y, Fairchild PJ, Tone M, Waldmann H. Expression of murine IL-12 is regulated by translational control of the p35 subunit. J Immunol 1999; 162: 4069-78.
33. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000; 13: 715-25.
34. Trinchieri G, Pflanz S, Kastelein RA. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 2003; 19: 641-644.
35. Belladonna ML, Renauld JC, Bianchi R, Vacca C, Fallarino F, Orabona C, et al. IL-23 and IL-12 have overlapping, but distinct, effects on murine dendritic cells. J Immunol 2002; 168: 5448-54.
36. Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, et al. IL-27, a heterodimeric cytokine composed of EB13 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 2002; 16: 779-90.
37. Devergne O, Hummel M, Koeppen H, Le Beau MM, Nathanson EC, Kieff E, et al. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J Virol 1996; 70: 1143-53.
38. Xu D, Chan WL, Leung BP, Hunter D, Schulz K, Carter RW, et al. Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. J Exp Med 1998; 188: 1485-92.
39. Micallef MJ, Ohtsuki T, Kohno K, Tanabe F, Ushio S, Namba M, et al. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur J Immunol 1996; 26: 1647-51.
40. Kohno K, Kataoka J, Ohtsuki T, Suemoto Y, Okamoto I, Usui M, et al. IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J Immunol 1997; 158: 1541-50.
41. Bird S, Zou J, Wang T, Munday B, Cunningham C, Secombes CJ. Evolution of interleukin-1beta. Cytokine Growth Factor Rev 2002; 13: 483-502.
42. Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, Fleming MA, et al. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 1997; 275: 206-9.
43. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A, et al. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 1997; 386: 619-23.
44. Bazan JF, Timans J, Kastelein R. A newly defined interleukin-1? Nature 1996; 379: 591.
45. Puren A, Fantuzzi G, Dinarello C. Gene expression, synthesis, and secretion of interleukin-18 and interleukin-1 beta are differentially regulated in human blood mononuclear cells and mouse spleen cells. Proc Natl Acad Sci USA 1999; 96: 2256-61.
46. Akita K, Ohtsuki T, Nukada Y, Tanimoto T, Namba M. Okura T, et al. Involvement of caspase-1 and caspase-3 in the production and processing of mature human interleukin 18 in monocytic THP.1 cells. J Biol Chem 1997; 272: 26595-603.
47. Schneider K, Puehler F, Baeuerle D, Elvers S, Staeheli P, Kaspers B, et al. cDNA cloning of biologically active chicken interleukin-18. J. Interferon Cytokine Res 2000; 20: 879-83
48. Kaiser, P. Turkey and chicken interleukin-18 (IL-18) share high sequence identity, but have different polyadenylation sites in their 3′UTR. Dev Comp Immunol 2002; 26: 681-7.
49. Zou J, Bird S, Truckle J, Bols N, Horne M, Secombes C. Identification and expression analysis of an IL-18 homologue and its alternatively spliced form in rainbow trout (Oncorhynchus mykiss). Eur J Biochem 2004; 271: 1913-23.
50. Morgan DA, Ruscetti FW, Gallo R. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 1976; 193: 1007-8.
51. Smith KA. T-cell growth factor. Immunol Rev 1980; 51: 337-57.
52. Smith KA. Interleukin-2: inception, impact, and implications. Science 1988; 240: 1169-76.
53. Hatakeyama M, Taniguchi T. Interleukin-2. In: Sporn MB, Roberts AB (Eds) Peptide growth factors and their receptors I. Springer, Berlin Heidelberg New York 1990; 523-40.
54. Swain SL. Lymphokines and the immune response: The central role of IL-2. Curr Opin Immunol 1991; 3: 304-10.
55. Waldmann TA, Dubois S, Tagaya Y. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunity 2001; 14: 105-10.
56. Robertson MJ, Ritz J. Biology and clinical relevance of human natural killer cells. Blood 1990; 76: 2421-38.
57. Mingari MC, Gerosa F, Carra G, Accolla RS, Moretta A, Zubler RH, et al. Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells. Nature 1984; 312: 641-3.
58. Waldmann TA, Goldman CK, Robb RJ, Depper JM, Leonard WJ, Sharrow SO, et al. Expression of interleukin 2 receptors on activated human B cells. J Exp Med 1984; 160: 1450-66.
59. Espinoza-Delgado I, Bosco MC, Musso T, Gusella GL, Longo DL, Varesio L. Interleukin-2 and human monocyte activation. J Leuk Biol 1995; 57: 13-9.
60. Ferrante A. Activation of neutrophils by interleukins-1 and -2 and tumor necrosis factors. Immunol Ser 1992; 57: 417-36.
61. Sundick RS, Gill-Dixon C. A cloned chicken lymphokine homologous to both mammalian IL-2 and IL-15. J Immunol 1997; 159: 720-5.
62. Kaiser P, Mariani P. Promoter sequence, exon:intron structure, and synteny of genetic location show that a chicken cytokine with T-cell proliferative activity is IL2 and not IL15. Immunogenetics 1999; 49: 26-35.
63. Bird S, Zou J, Kono T, Sakai M, Dijkstra JM, Secombes C. Characterisation and expression analysis of interleukin 2 (IL-2) and IL-21 homologues in the Japanese pufferfish, Fugu rubripes, following their discovery by synteny. Immunogenetics 2005; 56: 909-23.
64. Lillehoj HS, Min W, Choi KD, Babu US, Burnside J, Miyamoto T, et al. Molecular, cellular, and functional characterization of chicken cytokines homologous to mammalian IL-15 and IL-2. Vet Immunol Immunopathol 2001; 82: 229-44.
65. Stepaniak JA, Shuster JE, Hu W, Sundick RS. Production and in vitro characterization of recombinant chicken interleukin-2. J Interferon Cytokine Res 1999; 19: 515-26.
66. Krause H, Jandrig B, Wernicke C, Bulfone-Paus S, Pohl T, Diamantstein T. Genomic structure and chromosomal localization of the human interleukin 15 gene (IL-15). Cytokine 1996; 8: 667-74.
67. Parrish-Novak J, Foster DC, Holly RD, Clegg C. Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses. J Leuk Biol 2002; 72: 856-63.
68. Parrish-Novak J, Dillon SR, Nelson A, Hammond A, Sprecher C, Gross JA, et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 2000; 408: 57-63.
69. Vilcek J. The cytokines: an overview. In: Thomsom A (Ed), The cytokine handbook, 3rd edn. Academic, London 1998; 1-20.
70. Asano R, Kudo T, Makabe K, Tsumoto K, Kumagai I. Antitumor activity of interleukin-21 prepared by novel refolding procedure from inclusion bodies expressed in Escherichia coli. FEBS Lett 2002; 528: 70-6.
71. Strengell M, Sareneva T, Foster D, Julkunen I, Matikainen S. IL-21 up-regulates the expression of genes associated with innate immunity and Th1 response. J Immunol 2002; 169: 3600-5.
72. Munder M, Mallo M, Eichmann K, Modolell M. Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: A novel pathway of autocrine macrophage activation. J Exp Med 1998; 187: 2103-8.
73. Ohteki T, Fukao T, Suzue K, Maki C, Ito M, Nakamura M, et al. Interleukin 12-dependent interferon gamma production by CD8alpha+ lymphoid dendritic cells. J Exp Med 1999; 189: 1981-6.
74. Fukao T, Matsuda S, Koyasu S. Synergistic effects of IL-4 and IL-18 on IL-12-dependent IFN-gamma production by dendritic cells. J Immunol 2000; 164: 64-71.
75. Grogan JL, Mohrs M, Harmon B, Lacy DA, Sedat JW, Locksley RM. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity 2001; 14: 205-15.
76. Yoshimoto T, Takeda K, Tanaka T, Ohkusu K, Kashiwamura S, Okamura H, et al. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J Immunol 1998; 161: 3400-7.
77. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-gamma. Annu Rev Immunol 1997; 15: 749-95.
78. Kaiser P, Wain HM, Rothwell L. Structure of the chicken interferon-gamma gene, and comparison to mammalian homologues. Gene 1998; 207: 25-32.
79. Loa CC, Hsieh MK, Wu CC, Lin TL. Molecular identification and characterization of turkey IFN-gamma gene. Comp Biochem Physiol B Biochem Mol Biol 2001; 130: 579-84.
80. Huang A, Scougall CA, Lowenthal JW, Jilbert AR, Kotlarski I. Structural and functional homology between duck and chicken interferon-gamma. Dev Comp Immunol 2001; 25: 55-68.
81. Zou J, Yoshiura Y, Dijkstra JM, Sakai M, Ototake M, Secombes C. Identification of an interferon gamma homologue in Fugu, Takifugu rubripes. Fish Shellfish Immunol 2004; 17: 403-9.
82. Yoshiura Y, Dijkstra JM, Collet B, Ototake M, Zou J, Secombes CJ. Danio rerio IFNG mRNA for interferon gamma. GenBank Accession No. AB158361, 2003.
83. Zou J, Carrington A, Collet B, Dijkstra JM, Bols N, Secombes C. Identification and bioactivities of interferon gamma in rainbow trout, Oncorhynchus mykiss: The first Th1 type cytokine characterised functionally in fish. J Immunol 2005; 175: 2484-2494.
84. Graham S, Secombes CJ. Do fish lymphocytes secrete interferon? J Fish Biol 1990; 36: 563-73.
85. Scapigliati G, Bird S, Secombes CJ. Invertebrate and fish cytokines. Eur Cytokine Netw 2001; 11: 354-61.
86. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leuk Biol 2004; 75: 163-89.
87. Lambrecht B, Gonze M, Morales D, Meulemans G, van den Berg TP. Comparison of biological activities of natural and recombinant chicken interferon-gamma. Vet Immunol Immunopathol 1999; 70: 257-67.
88. Lawson S, Rothwell L, Lambrecht B, Howes K, Venugopal K, Kaiser P. Turkey and chicken interferon-gamma, which share high sequence identity, are biologically cross-reactive. Dev Comp Immunol 2001; 25: 69-82.
89. Kogut MH, Rothwell L, Kaiser P. IFN-gamma priming of chicken heterophils upregulates the expression of proinflammatory and Th1 cytokine mRNA following receptor-mediated phagocytosis of Salmonella enterica serovar enteritidis. J Interferon Cytokine Res 2005; 25: 73-81.
90. Subramaniam PS, Mujtaba MG, Paddy MR, Johnson HM. The carboxyl terminus of interferon-gamma contains a functional polybasic nuclear localization sequence. J Biol Chem 1999; 274: 403-7.
91. Subramaniam PS, Larkin J 3rd, Mujtaba MG, Walter MR, Johnson HM. The COOH-terminal nuclear localization sequence of interferon gamma regulates STAT1 alpha nuclear translocation at an intracellular site. J Cell Sci 2000; 113: 2771-81.
92. Deb DK, Sassano A, Lekmine F, Majchrzak B, Verma A, Kambhampati S, et al. Activation of protein kinase C delta by IFN-gamma. J Immunol 2003; 171: 267-73.
93. Ware C, Santee S, Glass A. Tumor necrosis factor - related ligands and receptors. In: Thomson AW. (Ed) The Cytokine Handbook. Academic Press, San Diego, CA 1998; 549-92.
94. Lawton P, Nelson J, Tizard R, Browning JL. Characterization of the mouse lymphotoxin-beta gene. J Immunol 1995; 154: 239-46.
95. Spies T, Morton CC, Nedospasov SA, Fiers W, Pious D, Strominger JL. Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex. Proc Natl Acad Sci USA 1986; 83: 8699-702.
96. Tite J, Powell M, Ruddle NH. Protein-antigen specific Ia restricted cytolytic T cells: analysis of frequency, target cell susceptibility and mechanism of cytolysis. J Immunol 1985; 135: 25-33.
97. Ferreri NR, Millet I, Askari B, Magnani P, Ruddle NH. Lymphotoxin-β and TNF regulation in T cell subsets: differential effects of PGE2. Cytokine 1997; 9: 157-65.
98. Cuff CA, Schwartz J, Bergman CM, Russell KS, Bender JR, Ruddle NH. Lymphotoxin alpha3 induces chemokines and adhesion molecules: insight into the role of LT alpha in inflammation and lymphoid organ development. J Immunol 1998; 161: 6853-60.
99. Pasparakis M, Alexopoulou L, Episkopou V, Kollias G. Immune and inflammatory responses in TNFα-deficient mice: a critical requirement for TNFα in the formation of networks and germinal centers, and in the maturation of humoral immune response. J Exp Med 1996; 184: 1397-411.
100. Marino M, Dunn A, Grail D, Inglese M, Noguchi Y, Richards E, et al. Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci USA 1997; 94: 8093-8.
101. Millet I, Ruddle NH. Differential regulation of lymphotoxin (LT), lymphotoxin-β (LT-β), and TNF-α in murine T cell clones activated through the TCR. J Immunol 1994; 152: 4336-46.
102. Suen WE, Bergman CM, Hjelmstrom P, Ruddle NH. A critical role for lymphotoxin in experimental allergic encephalomyelitis. J Exp Med 1997; 186: 1233-40.
103. Hirono I, Nam BH, Kurobe T, Aoki T. Molecular cloning, characterization, and expression of TNF cDNA and gene from Japanese flounder Paralychthys olivaceus. J Immunol 2000; 165: 4423-7.
104. Laing KJ, Wang T, Zou J, Holland J, Hong S, Bols N, et al. Cloning and expression analysis of rainbow trout Oncorhynchus mykiss tumour necrosis factor alpha. Eur J Biochem 2001; 268: 1315-22.
105. Zou J, Wang T, Hirono I, Aoki T, Inagawa H, Honda T, et al. Differential expression of two tumor necrosis factor genes in rainbow trout, Oncorhynchus mykiss. Dev Comp Immunol 2002; 26: 161-72.
106. Garcia-Castillo J, Pelegrin P, Mulero V, Meseguer J. Molecular cloning and expression analysis of tumor necrosis factor alpha from a marine fish reveal its constitutive expression and ubiquitous nature. Immunogenetics 2002; 54: 200-7.
107. Saeij JP, Stet RJ, de Vries BJ, van Muiswinkel WB, Wiegertjes GF. Molecular and functional characterization of carp TNF: a link between TNF polymorphism and trypanotolerance? Dev Comp Immunol 2003; 27: 29-41.
108. Savan R, Sakai M. Presence of multiple isoforms of TNF alpha in carp (Cyprinus carpio L.): genomic and expression analysis. Fish Shellfish Immunol 2004; 17: 87-94.
109. Zou J, Secombes CJ, Long S, Miller N, Clem LW, Chinchar VG. Molecular identification and expression analysis of tumor necrosis factor in channel catfish (Ictalurus punctatus). Dev Comp Immunol 2003; 27: 845-58.
110. Goetz FW, Planas JV, MacKenzie S. Tumor necrosis factors. Dev Comp Immunol 2004; 28: 487-97.
111. Savan R, Kono T, Igawa D, Sakai M. A novel tumor necrosis factor (TNF) gene present in tandem with the TNF-alpha gene on the same chromosome in teleosts. Immunogenetics 2005; 57: 140-50.
112. Altschul SF, Gish W, Miller W, Myers E, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215: 403-10.
113. Burge CB, Karlin S. Finding the genes in genomic DNA. Curr Opin Struct Biol 1998; 8: 346-54.
114. Pearson WR, Lipman DI. Improved tools for biological sequence comparison. Proc Natl Acad Sci USA 1988; 85: 2444-8.
115. Bird S, Secombes CJ. Xenopus tropicalis mRNA for Tumour necrosis factor alpha (TNF-α gene). GenBank accession No. AM041993, 2005.
116. Bird S, Secombes CJ. Xenopus tropicalis mRNA for lymphotoxin-alpha (LT-α gene). GenBank accession No. AM041994, 2005.
117. Bird S, Secombes CJ. Xenopus tropicalis mRNA for lymphotoxin-beta (LT-β gene). GenBank accession No. AM041995, 2005.
118. Sher A, Coffman RL. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu Rev Immunol 1992; 10: 385-409.
119. Urban JF Jr, Madden KB, Svetic A, Cheever A, Trotta PP, Gause WC, et al. The importance of Th2 cytokines in protective immunity to nematodes. Immunol Rev 1992; 127: 205-20.
120. Thompson-Snipes L, Dhar V, Bond MW, Mosmann TR, Moore KW, Rennick DM. Interleukin 10: a novel stimulatory factor for mast cells and their progenitors. J Exp Med 1991; 173: 507-10.
121. Van Snick J. Interleukin-6: an overview. Annu Rev Immunol 1990; 8: 253-78.
122. Petit-Frere C, Dugas B, Braquet P, Mencia-Huerta JM. Interleukin-9 potentiates the interleukin-4-induced IgE and IgG1 release from routine B lymphocytes. Immunology 1993; 79: 146-51.
123. Dugas B, Renauld JC, Pene J, Bonnefoy JY, Peti-Frere C, Braquet P, et al. Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes. Eur J Immunol 1993; 23: 1687-92.
124. Purkerson JM, Isakson PC. Isotype switching in anti-immunoglobulin-activated B-lymphoblasts - Differential requirements for interleukin-4 and other lymphokines to elicit membrane vs secreted igG1. Eur J Immunol 1992; 21: 707-14.
125. Gerondakis S. Structure and expression of murine germ-line immunoglobulin-epsilon heavy-chain transcripts induced by interleukin-4. Proc Natl Acad Sci USA 1990; 87: 1581-5.
126. Cocks BG, de Waal Malefyt R, Galizzi JP, de Vries JE, Aversa G. IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int Immunol 1993; 5: 657-63.
127. Brusselle G, Kips J, Joos G, Bluethmann H, Pauwels R. Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice. Amer J Respir Cell Mol Biol 1995; 12: 254-9.
128. Corry DB, Grunig G, Hadeiba H, Kurup VP, Warnock ML, Sheppard D, et al. Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice. Mol Med 1998; 4: 344-55.
129. Barner M, Mohrs M, Brombacher F, Kopf M. Differences between IL-4R alpha-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses. Curr Biol 1998; 8: 669-72.
130. Kaplan M, Schindler U, Smiley S, Grusby M. STAT6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 1996; 4: 313-9.
131. Shimoda K, van Deursen J, Sangster M, Sarawar S, Carson R, Tripp R, et al. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted STAT6 gene. Nature 1996; 380: 630-3.
132. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura, S, et al. Essential role of STAT6 in IL-4 signalling. Nature 1996; 380: 627-30.
133. Minty A, Chalon P, Derocq JM, Dumont X, Guillemot JC, Kaghad M, et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993; 362: 248-50.
134. McKenzie AN. Regulation of T helper type 2 cell immunity by interleukin-4 and interleukin-13. Pharmacol Ther 2000; 88: 143-51.
135. Punnonen J, Aversa G, Cocks BG, McKenzie AN, Menon S, Zurawski G, et al. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA 1993; 90: 3730-4.
136. Finkelman FD, Katona IM, Urban JF Jr, Holmes J, Ohara J, Tung AS, et al. IL-4 is required to generate and sustain in vivo IgE responses. J Immunol 1988; 141: 2335-41
137. Pene J, Rousset F, Briere F, Chretien I, Bonnefoy JY, Spits H, et al. IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons α, γ and prostaglandin E2. Proc Natl Acad Sci USA 1988; 85: 6880-4.
138. Emson CL, Bell SE, Jones A, Wisden W, McKenzie AN. Interleukin (IL)-4-independent induction of immunoglobulin (Ig)E, and perturbation of T cell development in transgenic mice expressing IL-13. J Exp Med 1998; 188: 399-404.
139. McKenzie GJ, Emson CL, Bell SE, Anderson S, Fallon P, Zurawski G, et al. Impaired development of Th2 cells in IL-13-deficient mice. Immunity 1998; 9: 423-32.
140. Madden KB, Urban JF Jr, Ziltener HJ, Schrader JW, Finkelman FD, Katona IM. Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis. J Immunol 1991; 147: 1387-91.
141. Renauld JC, Kermouni A, Vink A, Louahed J, Van Snick J. Interleukin-9 and its receptor: involvement in mast cell differentiation and T cell oncogenesis. J Leuk Biol 1995; 57: 353-60.
142. Temann UA, Geba GP, Rankin JA, Flavell RA. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J Exp Med 1998; 188: 1307-20.
143. Nilsson G, Nilsson K. Effects of interleukin (IL)-13 on immediate-early response gene expression, phenotype and differentiation of human mast cells. Comparison with IL-4. Eur J Immunol 1995; 25: 870-3.
144. Bradding P, Feather IH, Howarth PH, Mueller R, Roberts JA, Britten K, et al. Interleukin 4 is localized to and released by human mast cells. J Exp Med 1992; 176: 1381-6.
145. Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R, et al. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Amer J Respir Cell Mol Biol 1994; 10: 471-80.
146. Burd PR, Thompson WC, Max EE, Mills FC. Activated mast cells produce interleukin 13. J Exp Med 1995; 181: 1373-80.
147. Seder RA, Paul WE, Ben-Sasson SZ, LeGros GS, Kagey-Sobotka A, Finkelman FD, et al. Production of interleukin-4 and other cytokines following stimulation of mast cell lines and in vivo mast cells/basophils. Int Arch Allergy Appl Immunol 1991; 94: 137-40.
148. O'Shea JJ, Frucht DM, Duckett CS. Cytokines and cytokines receptors. In: Rich R, Fleisher TA, Shearer WT, Kotzin BL, Schroeder Jr HW (Eds). Clinical immunology: principles and practice (2nd Ed.), Mosby, St Louis 2001; 12.1-22.
149. Takatsu K, Dickason RR, Huston DP. Interleukin-5. In: Leroith D, Bondy C. (Eds) Growth factors and cytokines in health and disease Vol. 2A, JAI Press Inc, Greenwich 1997; 143-200.
150. Yamada T, Sun Q, Zeibecoglou K, Bungre J, North J, Kay AB, et al. IL-3, IL-5, granulocyte-colony-stimulating factor receptor alpha-subunit, and common beta-subunit expression by peripheral leukocytes and blood dendritic cells. J Allergy Clin Immunol 1998; 101: 677-82.
151. Sehmi R, Wood LJ, Watson R, Foley R, Hamid Q, O'Byrne PM, et al. Allergen-induced increases in IL-5 receptor alpha-subunit expression on bone marrow-derived CD34+ cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation. J Clin Invest 1997; 100: 2466-75.
152. Walsh GM, Hartnell A, Wardlaw AJ, Kurihara K, Sanderson CJ, et al. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. Int Arch Allergy Appl Immunol 1990; 71: 258-65.
153. Yamaguchi Y, Suda T, Ohta S, Tominaga K, Miura Y, Kasahara T. Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. Blood 1991; 78: 2542-7.
154. Kopf M, Brombacher F, Hodgkin PD, Ramsay AJ, Milbourne EA, Dai WJ, et al. IL-5-deficient mice have a developmental defect in CD5 + B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 1996; 4: 15-24.
155. Lee JJ, McGarry MP, Farmer SC, Denzler KL, Larson KA, Carrigan PE, et al. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med 1997; 185: 2143-56.
156. Clutterbuck EJ, Sanderson CJ. Regulation of human eosinophil precursor production by cytokines: a comparison of recombinant human interleukin-1 (rhIL-1), rhIL-3, rhIL-5, rhIL-6, and rh granulocyte-macrophage colony-stimulating factor. Blood 1990; 75: 1774-9.
157. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996; 183: 195-201.
158. Hogan SP, Matthaei KI, Young JM, Koskinen A, Young IG, Foster PS. A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5. J Immunol 1998; 161: 1501-9.
159. Grunig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, Rennick DM, et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998; 282: 2261-3.
160. Webb DC, McKenzie AN, Koskinen AM, Yang M, Mattes J, Foster PS. Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity. J Immunol 2000; 165: 108-13.
161. Finkelman FD, Shea-Donohue T, Goldhill J, Sullivan CA, Morris SC, Madden KB, et al. Cytokine regulation of host defense against parasitic gastrointestinal nematodes: lessons from studies with rodent models. Annu Rev Immunol 1997; 15: 505-33.
162. Folkard SG, Hogarth PJ, Taylor MJ, Bianco AE. Eosinophils are the major effector cells of immunity to microfilariae in a mouse model of onchocerciasis. Parasitology 1996; 112: 323-9.
163. Wynn, TA. IL-13 Effector Functions. Annu Rev Immunol 2003; 21: 425-56
164. Zurawski S, Vega F, Huyghe B, Zurawski G. Receptors for interleukin-13 and interleukin-4 are complex share a novel component that functions in signal transduction. EMBO J 1993; 12: 3899-905.
165. Lin J-X, Migone T-S, Tsang M, Friedmann M, Weatherbee J, Zhou L, et al. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13 and IL-5. Immunity 1995; 2: 331-9.
166. Noben-Trauth N, Shultz LD, Brombacher F, Urban JF Jr, Gu H, Paul WE. An interleukin 4 (IL-4)-independent pathway for CD4CT cell IL-4 production is revealed in IL-4 receptor-deficient mice. Proc Natl Acad Sci USA 1997; 94: 10838-43.
167. Urban JF Jr, Noben-Trauth N, Donaldson DD, Madden KB, Morris SC, Collins M, et al. IL-13, IL-4Ralpha, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity 1998; 8: 255-64.
168. McKenzie AN, Culpepper JA, de Waal Malefyt R, Briere F, Punnonen J, Aversa G, et al. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci USA 1993; 90: 3735-9.
169. Chiaramonte MG, Schopf LR, Neben TY, Cheever AW, Donaldson DD, Wynn TA. IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs. J Immunol 1999; 162: 920-30.
170. Rossi MI, de Oliveira Barreto E, Pires AL, Rossi MI, Dias VA, Cordeiro RS, et al. Long-term exacerbation by interleukin 13 of IgE-mediated eosinophilia in rats. Int Immunopharmacol 2005; 5: 1353-64.
171. Punnonen J, Aversa G, Cocks BG, de Vries JE. Role of interleukin-4 and interleukin-13 in synthesis of IgE and expression of CD23 by human B cells. Allergy 1994; 49: 576-86.
172. Renauld JC, Van Snick J. Interleukin-9. In: Thompson A. (Ed), The Cytokine Handbook, London 2003; 347-58.
173. Hültner L, Möller J. Mast cell growth-enhancing activity (MEA) stimulates interleukin 6 production in a mouse bone marrow-derived mast cell line and a malignant subline. Exp Hematol 1990; 18: 873-7
174. Louahed J, Kermouni A, Van Snick J, Renauld JC. IL-9 induces expression of granzymes and high-affinity IgE receptor in murine T helper clones. J Immunol 1995; 154: 5061-70.
175. Kishimoto T. Interleukin-6. In: The cytokine handbook (4th Edn). Thomson AN, Lotze MT (Eds). Academic Press, San Diego, CA 2003; 281-304.
176. Diehl S, Rincon, M. The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol 2002; 39: 531-6.
177. Kaplanski G, Marin V, Montero-Julian F, Mantovani A, Farnarier C. IL-6:
178. Suematsu S, Matsuda T, Aozasa K, Akira S, Nakano N, Ohno S, et al. IgG1 plasmacytosis in interleukin 6 transgenic mice. Proc Natl Acad Sci USA 1989; 86: 7547-51.
179. Roldan E, Brieva JA. Terminal differentiation of human bone marrow cells capable of spontaneous and high-rate immunoglobulin secretion: role of bone marrow stromal cells and interleukin 6. Eur J Immunol 1991; 21: 2671-7.
180. Chomarat P, Banchereau J, Davoust J, Palucka AK. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol 2000; 1: 510-4.
181. Bird S, Zou J, Savan R, Kono T, Sakai M, Woo J, et al. Characterisation and expression analysis of an interleukin 6 homologue in the Japanese pufferfish, Fugu rubripes. Dev Comp Immunol 2005; 29: 775-89.
182. Schneider K, Klaas R, Kaspers B, Staeheli P. Chicken interleukin-6. cDNA structure and biological properties. Eur J Biochem 2001; 268: 4200-6.
183. Kaiser P, Rothwell L, Goodchild M, Bumstead N. The chicken proinflammatory cytokines interleukin-1beta and interleukin-6: differences in gene structure and genetic location compared with their mammalian orthologues. Anim Genet 2004; 35: 169-75.
184. Kaiser P, Rothwell L, Avery S, Balu S. Evolution of the interleukins. Dev Comp Immunol 2004; 28: 375-94.
185. Weining KC, Sick C, Kaspers B, Staeheli P. A chicken homolog of mammalian interleukin-1 beta: cDNA cloning and purification of active recombinant protein. Eur J Biochem 1998; 258: 994-1000.
186. Nishimichi N, Aosasa M, Kawashima T, Horiuchi H, Furusawa S, Matsuda H. Biological activity of recombinant chicken interleukin-6 in chicken hybridoma cells. Vet Immunol Immunopathol 2005; 106: 97-105.
187. Avery S, Rothwell L, Degen WD, Schijns VE, Young J, Kaufman J, et al. Characterization of the first nonmammalian T2 cytokine gene cluster: the cluster contains functional single-copy genes for IL-3, IL-4, IL-13, and GM-CSF, a gene for IL-5 that appears to be a pseudogene, and a gene encoding another cytokinelike transcript, KK34. J Interferon Cytokine Res 2004; 24: 600-10.
188. Bird S, Secombes, CJ. Xenopus tropicalis mRNA for interleukin-4 (IL-4). GenBank Accession No. AM041996, 2005
189. Rost B, Sander C. Prediction of protein secondary structure at better than 70% accuracy. J Mol Biol 1993; 232: 584-99.
190. Hansen JD, Landis ED, Phillips RB. Discovery of a unique Ig heavy-chain isotype (IgT) in rainbow trout: Implications for a distinctive B cell developmental pathway in teleost fish. Proc Natl Acad Sci USA 2005; 102: 6919-24.
191. Reite OB, Evensen O. Inflammatory cells of teleostean fish. A review focusing on mast cells/eosinophilic granule cells and rodlet cells. Fish Shellfish Immunol 2005; 20(2): 192-208.
192. Stavnezer J, Amemiya CT. Evolution of isotype switching. Semin Immunol 2004; 16: 257-75.
193. Danilova N, Bussmann J, Jekosch K, Steiner LA. The immunoglobulin heavy-chain locus in zebrafish: identification and expression of a previously unknown isotype, immunoglobulin Z. Nat Immunol 2005; 6: 295-302.
194. Boulay JL, O'Shea JJ, Paul WE. Molecular phylogeny within type I cytokines and their cognate receptors. Immunity 2003; 19: 159-63.
195. Bazan JF. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 1990; 87: 6934-8.
196. Renauld JC. Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat Rev Immunol 2003; 3: 667-76.
197. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994; 76: 241-51.
198. Leonard, WJ. Type I cytokines and interferons and their receptors. In: Paul WE. (Ed) Fundemental Immunology, Lippincott-Raven, Philadelphia 2003; 701-48.
199. McKenzie AN, Li X, Largaespada DA, Sato A, Kaneda A, Zurawski SM, et al. Structural comparison and chromosomal localization of the human and mouse IL-13 genes. J Immunol 1993; 150: 5436-44.
200. Smirnov DV, Smirnova MG, Korobko VG, Frolova EI. Tandem arrangement of human genes for interleukin-4 and interleukin-13: resemblance in their organization. Gene 1995; 155: 277-81.
201. Leonard WJ. Cytokines and immunodeficiency diseases. Nat Rev Immunol 2001; 1: 200-8.
202. Leonard WJ. TSLP: finally in the limelight. Nat Immunol 2002; 3: 605-7.
203. Sivakumar PV, Foster DC, Clegg CH. Interleukin-21 is a T-helper cytokine that regulates humoral immunity and cell-mediated anti-tumour responses. Immunology 2004; 112: 177-82.
204. Demoulin JB, Renauld JC. Signalling by cytokines interacting with the interleukin-2 receptor gamma chain. Cytokines Cell Mol Ther 1998; 4: 243-56.
205. Benczik M, Gaffen SL. The interleukin (IL)-2 family cytokines: survival and proliferation signaling pathways in T lymphocytes. Immunol Invest 2004; 33: 109-42.
206. Kovanen PE, Leonard WJ. Cytokines and immunodeficiency diseases: critical roles of the gamma(c)-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways. Immunol Rev 2004; 2202: 67-83.
207. Noguchi M, Adelstein S, Cao X, Leonard WJ. Characterization of the human interleukin-2 receptor gamma chain gene. J Biol Chem 1993; 268: 13601-8.
208. Wang T, Secombes CJ. Cloning and expression of a putative common cytokine receptor gamma chain (gamma C) gene in rainbow trout (Oncorhynchus mykiss). Fish Shellfish Immunol 2001; 11: 233-44.
209. Ozaki K, Leonard WJ. Cytokine and cytokine receptor pleiotropy and redundancy. J Biol Chem 2002; 277: 29355-8.
210. Miyajima A, Kinoshita T, Tanaka M, Kamiya A, Mukouyama Y, Hara T. Role of Oncostatin M in hematopoiesis and liver development. Cytokine Growth Factor Rev 2000; 11: 177-83.
211. Pennica D, Wood WI, Chien KR. Cardiotrophin-1: a multifunctional cytokine that signals via LIF receptor-gp 130 dependent pathways. Cytokine Growth Factor Rev 1996; 7: 81-91.
212. Miyajima A, Mui AL, Ogorochi T, Sakamaki K. Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood 1993; 82: 1960-74.
213. Martinez-Moczygemba M, Huston DP. Biology of common beta receptor-signaling cytokines: IL-3, IL-5, and GM-CSF. J Allergy Clin Immunol 2003; 112: 653-65.
214. Foster D, Parrish-Novak J, Fox B, Xu W. Cytokine-receptor pairing: accelerating discovery of cytokine function. Nat Rev Drug Discov 2004; 3: 160-170.
215. Lockyer AE, Jones CS, Noble LR, Verspoor E, Holland J, Secombes CJ. Isolation and characterisation of a putative interleukin-13 receptor α2 sequence from rainbow trout (Oncorhynchus mykiss). Fish Shellfish Immunol 2001; 11: 541-6.
216. Caput D, Laurent P, Kaghad M, Lelias JM, Lefort S, Vita N, et al. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor α chain. J Biol Chem 1996; 271: 16921-6.
217. Donaldson DD, Whitters MJ, Fitz LJ, Neben TY, Finnerty H, Henderson SL, et al. The murine IL-13 receptor α2: Molecular cloning, characterization and comparison with murine IL-13 receptor α1. J Immunol 1998; 161: 2317-24.
218. Feng NP, Lugli SM, Schnyder B, Gauchat JFM, Graber P, Schlagenhauf E, et al. The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: overexpression of the non-signalling interleukin-13 receptor alpha 2. Lab Invest 1998; 78: 591-602.
219. Finkelman FD, Wynn TA, Donaldson DD, Urban JF Jr. The role of IL-13 in helminth-induced inflammation and protective immunity against nematode infections. Curr Opin Immunol 1999; 11: 420-6.
220. Orchansky PL, Ayres SD, Hilton DJ, Schrader JW. An interleukin (IL)-13 receptor lacking in the cytoplasmic domain fails to transduce IL-13-induced signals and inhibits responces to IL-4. J Biol Chem 1997; 272: 22940-7.
221. Orchansky PL, Kwan R, Lee F, Schrader JW. Characterization of the cytoplasmic domain of interleukin-13 receptor α. J Biol Chem 1999; 274: 20818-25.
222. Murata T, Obiri NI, Depinski W, Puri RK. Structure of IL-13 receptor: Analysis of subunit composition in cancer and immune cells. Biochem Biophys Comm 1997; 238: 90-4.
223. Seder RA, Marth T, Sieve MC, Strober W, Letterio JJ, Roberts AB, et al. Factors involved in the differentiation of TGF-beta-producing cells from naive CD4+ T cells: IL-4 and IFN-gamma have opposing effects, while TGF-beta positively regulates its own production. J Immunol 1998; 160: 5719-28.
224. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999; 190: 995-1004.
225. Read S, Malmstrom V, Powrie F. Cytotoxic T-lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation. J Exp Med 2000; 192: 295-302.
226. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170: 2081-95.
227. Ding YZ, Fu S, Zamarin D. Interleukin-10. In: Thomson AW, Lotze MT, (Eds) The Cytokine Handbook (4th Edn). Academic Press, London 2003; 603-25.
228. deWaal Malefyt R, Abrams J, Bennett B, Figdor C, de Vries J. IL-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209-20.
229. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, et al. IL-10 acts on the antigen presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991; 146: 3444-51.
230. Fiorentino DF, Zlotnik A, Mosmann TR, Howard MH, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147: 3815-22.
231. Ding L, Shevach EM. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J Immunol 1992; 148: 3133-9.
232. Hsu D-H, Moore KW, Spits H. Differential effects of interleukin-4 and -10 on interleukin-2-induced interferon-γ synthesis and lymphokine-activated killer activity. Int Immunol 1992; 4: 563-69.
233. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 219: 683-765.
234. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991; 174: 1549-55.
235. deWaal Malefyt R, Haanen J, Spits H, Roncarolo M-G, te Velde A, Figdor C, et al. IL-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II MHC expression. J Exp Med 1991; 174: 915-24.
236. Ding L, Linsley PS, Huang L-Y, Germain RN, Shevach EM. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 1993; 151: 1224-34.
237. Gazzinelli RT, Oswald IP, James SL, Sher A. IL-10 inhibits parasite killing and nitric oxide production by IFN-γ-activated macrophages. J Immunol 1992; 148: 1792-6.
238. Oswald IP, Gazzinelli RT, Sher A, James SL. IL-10 synergizes with IL-4 and TGF-beta to inhibit macrophage cytotoxic activity. J Immunol 1992; 148: 3578-82.
239. Ralph P, Nakoinz I, Sampson-Johannes A, Fong S, Lowe D, Min H-Y, et al. IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J Immunol 1992; 148: 808-14.
240. Murphy EE, Terres G, Macatonia SE, Hsieh C-S, Mattson J, Lanier L, et al. B7 and interleukin-12 cooperate for proliferation and IFN production by mouse Th1 clones that are unresponsive to B7 costimulation. J Exp Med 1994; 180: 223-31.
241. Bettelli E, Das MP, Howard ED, Weiner HL, Sobel RA, Kuchroo VK. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J Immunol 1998; 161: 3299-306.
242. Kotenko SV, Saccani S, Izotova LS, Mirochnitchenko OV, Pestka S. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci USA 2000; 97: 1695-700.
243. Buelens C, Willems F, Pierard G, Delvaux A, Velu T, Goldman M. IL-10 inhibits the primary allogeneic T cell response to human peripheral blood dendritic cells. Adv Exp Med Biol 1995; 378: 363-5.
244. Macatonia SE, Doherty TM, Knight SC, O'Garra A. Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. Immunology 1993; 150: 3755-65.
245. Cassatella MA, Meda L, Bonora S, Ceska M, Constantin G. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 1993; 178: 2207-11.
246. Gasperini S, Marchi M, Calzetti F, Laudanna C, Vicentini L, Olsen H, et al. Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils. J Immunol 1999; 162: 4928-37.
247. Go NF, Castle BE, Barrett R, Kastelein R, Dang W, Mosmann TR, et al. Interleukin 10 (IL-10), a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J Exp Med 1990; 172: 1625-31.
248. Burdin N, Van Kooten C, Galibert L, Abrams JS, Wijdenes J, Banchereau J, et al. Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes. J Immunol 1995; 154: 2533-44.
249. Punnonen J, de Waal Malefyt R, van Vlasselaer P, Gauchat J-F, de Vries JE. IL-10 and viral IL-10 prevent IL-4-induced IgE synthesis by inhibiting the accessory cell function of monocytes. J Immunol 1993; 151: 1280-9.
250. Nonoyama S, Hollenbaugh D, Aruffo A, Ledbetter JA, Ochs HD. B cell activation via CD40 is required for specific antibody production by antigenstimulated human B cells. J Exp Med 1993 178: 1097-102.
251. Garrone P, Galibert L, Rousset F, Banchereau J. Regulatory effects of prostaglandin E2 on the growth and differentiation of human B lymphocytes activated through their CD40 antigen. J Immunol 1994; 152: 82-90.
252. Uejima Y, Takahashi K, Komoriya K, Kurozumi S, Ochs HD. Effect of interleukin-10 on anti-CD40- and interleukin-4-induced immunoglobulin E production by human lymphocytes. Int Arch Allergy Immunol 1996; 110: 225-32.
253. Levan-Petit I, Lelievre E, Barra A, Limosin A, Gombert B, Preud'homme JL, et al. T(h)2 cytokine dependence of IgD production by normal human B cells. Int Immunol 1999; 11: 1819-28.
254. Shelburne CP, Ryan JJ. The role of Th2 cytokines in mast cell homeostasis. Immunol Rev 2001; 179: 82-93.
255. Rothwell L, Young JR, Zoorob R, Whittaker CA, Hesketh P, Archer A, et al. Cloning and characterization of chicken IL-10 and its role in the immune response to Eimeria maxima. J Immunol 2004; 173: 2675-82.
256. Zou J, Clark MS, Secombes CJ. Characterisation, expression and promoter analysis of an interleukin 10 homologue in the puffer fish, Fugu rubripes. Immunogenetics 2003; 55: 325-35.
257. Lutfalla G, Crollius HR, Stange-Thomann N, Jaillon O, Mogensen K, Monneron D. Comparative genomic analysis reveals independent expansion of a lineage-specific gene family in vertebrates: the class II cytokine receptors and their ligands in mammals and fish. BMC Genomics 2003; 4: 29.
258. Savan R, Igawa D, Sakai M. Cloning, characterization and expression analysis of interleukin-10 from the common carp, Cyprinus carpio L. Eur J Biochem 2003; 270: 4647-54.
259. Inoue Y, Kamota S, Ito K, Yoshiura Y, Ototake M, Moritomo T, et al. Molecular cloning and expression analysis of rainbow trout (Oncorhynchus mykiss) interleukin-10 cDNAs. Fish Shellfish Immunol 2005; 18: 335-44.
260. Kotenko SV. The family of IL-10-related cytokines and their receptors: related, but to what extent? Cytokine Growth Factor Rev 2002; 13: 223-40.
261. Zou J, Bird S, Secombes C. Fish cytokine gene discovery and linkage using genomic approaches. Mar Biotechnol 2004; 6: S533-9.
262. Derynck R, Akhurst RJ, Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 2001; 29: 117-29.
263. Moustakas A, Souchelnytskyi S, Heldin CH. Smad regulation in TGF-beta signal transduction. J Cell Sci 2001; 114: 4359-69.
264. Graycar JL, Miller DA, Arrick BA, Lyons RM, Moses HL, Derynck R. Human transforming growth factor-beta 3: recombinant expression, purification, and biological activities in comparison with transforming growth factors-beta 1 and -beta 2. Mol Endocrinol 1989; 3: 1977-86.
265. Attisano L, Wrana JL. Signal transduction by members of the transforming growth factor-beta superfamily. Cytokine Growth Factor Rev 1996; 7: 327-39.
266. Attisano L, Wrana JL. Signal transduction by the TGF-beta super-family. Science 2002; 296: 1646-7.
267. Letterio JJ, Roberts AB. Transforming growth factor-beta1-deficient mice: identification of isoform-specific activities in vivo. J Leuk Biol 1996; 59: 769-74.
268. Bottinger EP, Letterio JJ, Roberts AB. Biology of TGF-beta in knockout and transgenic mouse models. Kidney Int 1997; 51: 1355-60.
269. Kehrl JH. Transforming growth factor-beta: an important mediator of immunoregulation. Int J Cell Cloning 1991; 9: 438-50.
270. O'Kane S, Ferguson MW. Transforming growth factor β's and wound healing. Int J Biochem Cell Biol 1997; 29: 63-78.
271. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998; 16: 137-61.
272. Roberts AB, Sporn MB. The transforming growth factor β's: In: Handbook of Experimental Pharmacology, Peptide Growth Factors and Their Receptors. Sporn MB, and Roberts AB. (Eds). Springer-Verlag, New York 1990; 419-72.
273. Wahl SM, McCartney-Francis N, Mergenhagen SE. Inflammatory and immunomodulatory roles of TGF-beta. Immunol Today 1989; 10: 258-61.
274. Wiseman DM, Polverini PJ, Kamp DW, Leibovich SJ. Transforming growth factor-beta (TGF beta) is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem Biophys Res Commun 1988; 157: 793-800.
275. McCartney-Francis N, Mizel D, Wong H, Wahl L, Wahl S. TGF-beta regulates production of growth factors and TGF-beta by human peripheral blood monocytes. Growth Factors 1990; 4: 27-35.
276. Welch GR, Wong HL, Wahl SM. Selective induction of Fc gamma RIII on human monocytes by transforming growth factor-beta. J Immunol 1990: 144: 3444-8.
277. Rose DM, Fadok VA, Riches DW, Clay KL, Henson PM. Autocrine/paracrine involvement of platelet-activating factor and transforming growth factor-beta in the induction of phosphatidyl-serine recognition by murine macrophages. J Immunol 1995; 155: 5819-25.
278. Fargeas C, Wu CY, Nakajima T, Cox D, Nutman T, Delespesse G. Differential effect of transforming growth factor beta on the synthesis of Th1- and Th2-like lymphokines by human T lymphocytes. Eur J Immunol 1992; 22: 2173-6.
279. Turner M, Chantry D, Katsikis P, Berger A, Brennan FM, Feldmann M. Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-beta. Eur J Immunol 1991; 21: 1635-9.
280. Bogdan C, Nathan C. Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10. Ann N Y Acad Sci 1993; 685: 713-39.
281. Vodovotz Y, Bogdan C. Control of nitric oxide synthase expression by transforming growth factor-beta: implications for homeostasis. Prog Growth Factor Res 1994; 5: 341-51.
282. Strobl H, Riedl E, Scheinecker C, Bello-Fernandez C, Pickl WF, Rappersberger K, et al. TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors. J Immunol 1996; 157: 1499-507.
283. Riedl E, Strobl H, Majdic O, Knapp W. TGF-beta 1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis. J Immunol 1997; 158: 1591-7.
284. Stavnezer J. Transforming growth factor beta. In: Cytokine Regulation of Humoral Immunity: Basic and Clinical Aspects. Snapper CM. (Ed), Wiley, New York 1996; 289-324.
285. Kehrl JH, Roberts AB, Wakefield RM, Jakowlew S, Sporn MB, Fauci AS. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. J Immunol 1986; 137: 3855-60.
286. Smeland EB, Blomhoff HK, Holte H, Ruud E, Beiske K, Funderud S, et al. Transforming growth factor beta (TGF-beta) inhibits G1 to S transition, but not activation of human B lymphocytes. Exp Cell Res 1987; 171: 213-22.
287. Kehrl JH, Thevenin C, Rieckmann P, Fauci AS. Transforming growth factor-beta suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA. J Immunol 1991; 146: 4016-23.
288. Snapper CM, Waegell W, Beernink H, Dasch JR. Transforming growth factor-beta 1 is required for secretion of IgG of all subclasses by LPS-activated murine B cells in vitro. J Immunol 1993; 151: 4625-36.
289. Tang J, Nuccie BL, Ritterman I, Liesveld JL, Abboud CN, Ryan DH. TGF-beta down-regulates stromal IL-7 secretion and inhibits proliferation of human B cell precursors. J Immunol 1997; 159: 117-25.
290. Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-Mon M, Derynck R, et al. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986; 163: 1037-50.
291. Cerwenka A, Bevec D, Majdic O, Knapp W, Holter W. TGF-β1 is a potent inducer of human effector T cells. J Immunol 1994; 153: 4367-77.
292. Cerwenka A, Kovar H, Majdic O, Holter W. Fas- and activation-induced apoptosis are reduced in human T cells preactivated in the presence of TGF-β1. J Immunol 1996; 156: 459-64.
293. Rich S, Van Nood N, Lee HM. Role of alpha 5 beta 1 integrin in TGF-β1-costimulated CD8+ T cell growth and apoptosis. J Immunol 1996; 157: 2916-23.
294. Zhang X, Giangreco L, Broome HE, Dargan CM, Swain SL. Control of CD4 effector fate: transforming growth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion. J Exp Med 1995; 182: 699-709.
295. Pan H, Halper J. Cloning, expression, and characterization of chicken transforming growth factor beta 4. Biochem Biophys Res Commun 2003; 303: 24-30.
296. Pan H, Halper J. Regulation of heat shock protein 47 and type I procollagen expression in avian tendon cells. Cell Tissue Res 2003; 311: 373-82.
297. Halper J, Burt DW, Romanov MN. On reassessment of the chicken TGFB4 gene as TGFB1. Growth Factors 2004; 22: 121-2.
298. Kondaiah P, Sands MJ, Smith JM, Fields A, Roberts AB, Sporn MB, et al. Identication of a novel Transforming Growth factor-b 5 (TGF-b5) mRNA in Xenopus laevis. J Biol Chem 1990; 265: 1089-93.
299. Rebbert ML, Bharia-Dey N, Dawid IB. The sequence of TGFβ2 from Xenopus laevis. Nucleic Acids Res 1990; 18: 2185.
300. Hardie LJ, Laing KJ, Daniels GD, Grabowski PS, Cunningham C, Secombes CJ. Isolation of the first piscine transforming growth factor beta gene: analysis reveals tissue specific expression and a potential regulatory sequence in rainbow trout (Oncorhynchus mykiss). Cytokine 1998; 10: 555-63.
301. Zhan Y, Jimmy K. Molecular isolation and characterisation of carp transforming growth factor beta 1 from activated leucocytes. Fish Shellfish Immunol 2000; 10: 309-18.
302. Tafalla C, Aranguren R, Secombes CJ, Castrillo JL, Novoa B, Figueras A. Molecular characterisation of sea bream (Sparus aurata) transforming growth factor beta1. Fish Shellfish Immunol 2003; 14: 405-21.
303. Harms CA, Kennedy-Stoskopf S, Horne WA, Fuller FJ, Tompkins WA. Cloning and sequencing hybrid striped bass (Morone saxatilis × M. chrysops) transforming growth factor-beta (TGF-beta), and development of a reverse transcription quantitative competitive polymerase chain reaction (RT-qcPCR) assay to measure TGF-beta mRNA of teleost fish. Fish Shellfish Immunol 2000; 10: 61-85.
304. Laing KJ, Cunningham C, Secombes CJ. Genes for three different isoforms of transforming growth factor-beta are present in plaice (Pleuronectes platessa) DNA. Fish Shellfish Immunol 2000; 10: 261-71.
305. Vempati UD, Kondaiah P. Molecular organization of the gene encoding Xenopus laevis transforming growth factor-beta 5. Biochem Mol Biol Int 1998; 45: 997-1003.
306. Daniels GD, Secombes CJ. Genomic organisation of rainbow trout, Oncorhynchus mykiss TGF-beta. Dev Comp Immunol 1999; 23: 139-47.
307. Jang SI, Hardie LJ, Secombes CJ. Effects of transforming growth factor beta 1 on rainbow trout Oncorhynchus mykiss macrophage respiratory burst activity. Dev Comp Immunol 1994; 18: 315-23.
308. Jang SI, Hardie LJ, Secombes CJ. Elevation of rainbow trout Oncorhynchus mykiss macrophage respiratory burst activity with macrophage-derived supernatants. J Leuk Biol 1995; 57: 943-7.
309. Sumathy K, Desai KV, Kondaiah P. Isolation of transforming growth factor-beta2 cDNA from a fish, Cyprinus carpio by RT-PCR. Gene 1997; 191: 103-7.
310. Cheah FS, Jabs EW, Chong SS. Genomic, cDNA, and embryonic expression analysis of zebrafish transforming growth factor beta 3 (tgfbeta3). Dev Dyn 2005; 232: 1021-30.
311. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The ClustalX windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997; 24: 4876-82.
312. Page RDM. TREEVIEW: An application to display phylogenetic trees on personal computers. Comp Appl Biosci 1996; 12: 357-8.
313. Dezfouli S, Hatzinisiriou I, Ralph SJ. Use of cytokines in cancer vaccines/immunotherapy: recent developments improve survival rates for patients with metastatic malignancy. Curr Pharm Des 2005; 11(27): 3511-30.
314. Koussounadis AI, Ritchie DW, Kemp GJ, Secombes CJ. Analysis of fish IL-1beta and derived peptide sequences indicates conserved structures with species-specific IL-1 receptor binding: implications for pharmacological design. Curr Pharm Des 2004; 10(31): 3857-71.
315. Wu Z, MacPhee IA, Oliveira DB. Reactive oxygen species in the initiation of IL-4 driven autoimmunity as a potential therapeutic target. Curr Pharm Des 2004; 10(8): 899-913.